BARALDI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 9.196
NA - Nord America 6.676
AS - Asia 2.647
SA - Sud America 452
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 72
OC - Oceania 36
Totale 19.230
Nazione #
IT - Italia 6.676
US - Stati Uniti d'America 6.439
GB - Regno Unito 1.024
SG - Singapore 828
CN - Cina 570
BR - Brasile 338
VN - Vietnam 318
HK - Hong Kong 313
FR - Francia 274
SE - Svezia 194
DE - Germania 189
NL - Olanda 180
RU - Federazione Russa 137
CA - Canada 106
BD - Bangladesh 103
IN - India 83
CH - Svizzera 74
KR - Corea 74
UA - Ucraina 73
FI - Finlandia 68
TR - Turchia 65
ID - Indonesia 59
MX - Messico 54
ES - Italia 52
JP - Giappone 47
AR - Argentina 43
PL - Polonia 43
BG - Bulgaria 40
IE - Irlanda 37
AU - Australia 34
ZA - Sudafrica 23
IQ - Iraq 20
AE - Emirati Arabi Uniti 19
EC - Ecuador 19
CR - Costa Rica 18
CO - Colombia 17
EG - Egitto 17
IL - Israele 17
IR - Iran 17
PK - Pakistan 17
BE - Belgio 16
TW - Taiwan 16
AT - Austria 15
PH - Filippine 15
MY - Malesia 11
NO - Norvegia 11
DK - Danimarca 10
GT - Guatemala 10
HU - Ungheria 10
CZ - Repubblica Ceca 9
LT - Lituania 9
SV - El Salvador 9
CL - Cile 8
GR - Grecia 8
JM - Giamaica 8
NP - Nepal 8
AL - Albania 7
HN - Honduras 7
JO - Giordania 7
PT - Portogallo 7
DZ - Algeria 6
PE - Perù 6
PY - Paraguay 6
TN - Tunisia 6
UY - Uruguay 6
BY - Bielorussia 5
KG - Kirghizistan 5
MA - Marocco 5
PR - Porto Rico 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
KE - Kenya 4
RS - Serbia 4
SC - Seychelles 4
AM - Armenia 3
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
MD - Moldavia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
CU - Cuba 2
GP - Guadalupe 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
MT - Malta 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
A1 - Anonimo 1
Totale 19.063
Città #
Ashburn 892
Southend 725
Milan 614
Singapore 515
Santa Clara 510
Fairfield 507
Rome 413
San Jose 331
Chandler 315
Hong Kong 302
Woodbridge 254
Council Bluffs 243
Houston 215
Seattle 215
Cambridge 178
Wilmington 164
Naples 151
Modena 144
Hefei 126
London 126
Beijing 121
Turin 120
Nyköping 119
New York 113
Bologna 104
Los Angeles 104
Ho Chi Minh City 102
Florence 95
Ann Arbor 86
Dearborn 82
The Dalles 82
Chicago 80
Hanoi 73
Seoul 59
Catania 58
Genoa 57
Palermo 56
Bari 53
Jacksonville 53
Helsinki 50
Verona 49
Dallas 48
Lauterbourg 48
Jakarta 47
Parma 46
São Paulo 44
Moscow 42
San Diego 42
Pescara 39
Cagliari 36
Shanghai 36
Princeton 33
Boston 32
Sofia 31
Buffalo 30
Orem 30
Toronto 30
Salt Lake City 28
Zurich 28
Atlanta 26
Mexico City 26
Phoenix 26
Redwood City 25
Tokyo 25
Como 23
Munich 23
Warsaw 23
Brescia 22
Amsterdam 21
Eugene 21
Frankfurt am Main 20
L’Aquila 20
Dublin 19
Elk Grove Village 19
Fremont 19
Brooklyn 18
Chennai 18
Columbus 18
Messina 18
Paris 18
Philadelphia 18
Tampa 18
Montreal 17
Monza 17
Padova 17
Reggio Emilia 17
Ventimiglia 17
Bergamo 16
Dalmine 16
Denver 16
Perugia 16
San José 16
Brasília 15
Bremen 15
Da Nang 15
Haiphong 15
Manchester 15
Washington 15
Anápolis 14
Düsseldorf 14
Totale 10.093
Nome #
Correlazione tra fumo di cannabis e pneumotorace spontaneo. 7.010
Allopregnanolone serum levels in female migraineurs 938
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 687
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 534
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 446
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 418
Monitoring of adherence to headache treatments by means of hair analysis 416
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 414
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 390
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 369
Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers. A case-control study. 351
A case-control study of visually evoked postural responses in childhood with primary headaches 346
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 330
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 322
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 320
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache 313
Erenumab per il trattamento preventivo dell'emicrania cronica: efficacia e sicurezza fino a un anno, predittori di risposta ed effetti della sospensione. 311
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 302
Glutamate receptor antagonists with the potential for migraine treatment 297
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 292
Proteomic serum profile of female migraineurs 289
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 287
Hair testing as a marker of adherence to headache treatments 284
Polypharmacy Among Headache Patients: A Cross-Sectional Study 281
Proteomic serum profile in menstrual-related and post menopause migraine 265
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 256
Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive age 251
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 234
Occlusal splint therapy in patients with Ménière’s disease and temporomandibular joint disorder 218
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 215
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 210
Visually Evoked Postural Responses (VEPRs) in Children with Vestibular Migraine 204
Topical Cannabidiol in the Treatment of digital ulcers in patients with Scleroderma: comparative Analysis and Literature Review 193
OnabotulinumtoxinA: Still the Present for Chronic Migraine 183
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 173
Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real-world clinical evidence in a severely impaired patient population 170
Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study 165
Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study 164
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 136
Correction to: Monoclonal anti‑CGRP antibodies in post‑menopausal women: a real‑life study (Acta Neurologica Belgica, (2023), 123, 3, (1039-1047), 10.1007/s13760-023-02190-5) 124
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study 122
Totale 19.230
Categoria #
all - tutte 53.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022928 0 0 0 0 48 79 64 116 127 117 220 157
2022/20232.537 166 191 187 224 189 230 188 229 305 139 252 237
2023/20242.547 212 213 227 207 265 193 238 221 160 185 225 201
2024/20253.140 178 151 145 267 432 385 259 206 333 195 279 310
2025/20264.174 332 170 260 540 751 247 506 196 362 369 228 213
2026/20271.534 288 263 253 573 157 0 0 0 0 0 0 0
Totale 19.230